| [Fire Fighting] Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire. | |
| [Ingestion] Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended. | |
| [Inhalation] If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention. | |
| [Skin] Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes. | |
| [Eyes] If symptoms develop, immediately move individual away from exposure and into fresh air. Flush eyes gently with water for at least 15 minutes while holding eyelids apart; seek immediate medical attention. | |
| [Storage] Keep in a cool, dry, well-ventilated area in a sealed container. | |
| [Handling] Keep container closed when not in use. Avoid contact. Follow label directions. | |
| [Personal Protection] Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots. | |
| [Respirators] Where environmental controls are lacking or in an enclosed space, use a NIOSH/MSHA approved respirator for dust. | |
| [Exposure Effects] Allergic skin and respiratory reactions have been reported. | |
| [Appearance] Crystals. | |
| [Solubility in water] Insoluble | |
| [Melting Point] 109 - 110 | |
| [pKa/pKb] 6.42 (pKb) | |
| [Usage] Medication. | |
| [Product Name] Erythromycin ethylsuccinate | |
| [Synonyms] Eritrocina Erythromycin, 2'-(ethyl butanedioate) Ethyl [(2R,3S,4R,6S)-4-dimethylamino-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2S,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-1-oxacyclotetradec-6-yl]oxy]-6-methyl-oxan-3-yl] butanedioate Monomycin Paediathrocin Succinic acid, monoester with erythromycin | |
| [CAS] 1264-62-6 | |
| [Formula] C43H75NO16 | |
| [Molecular Weight] 862.06 | |
| [EINECS] 215-033-8 | |
| [RTECS] WM9800000 | |
| [RTECS Class] Drug; Human Data | |
| [Beilstein/Gmelin] 77638 | |
| [Beilstein Reference] 4-18-00-07416 | |
| [Small spills/leaks] Ventilate area. Use protective eqiupment. Sweep or vacuum up. Do not creat dust. Place in a dry container for disposal. Clean spill area with water. | |
| [Stability] Stable. | |
| [Incompatibilities] Strong oxidizing agents. | |
| [Decomposition] None reported. |
Print